Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder

References

• World Health Organization. The world health report -mental health: new understanding, new hope. WHO, Geneva 2001; 2001
   Google Scholar
• Arroll B, Macgillivray S, Ogston S, et al. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med 2005; 3: 449–456
   PubMed Web of Science ®Google Scholar
• Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996; 19: 179–200
   PubMed Web of Science ®Google Scholar
• Kessler RC, Davis RB, Foster DF, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001; 135: 262–268
   PubMed Web of Science ®Google Scholar
• Silvers KM, Woolley CC, Hedderley D. Dietary supplement use in people being treated for depression. Asia Pac J Clin Nutr 2006; 15: 30–34
   PubMed Web of Science ®Google Scholar
• Mamalakis G, Kalogeropoulos N, Andrikopoulos N, et al. Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete. Eur J Clin Nutr 2006; 60: 882–888
   PubMed Web of Science ®Google Scholar
• Mamalakis G, Jansen E, Cremers H, Kiriakakis M, Tsibinos G, Kafatos A. Depression and adipose and serum cholesteryl ester polyunsaturated fatty acids in the survivors of the seven countries study population of Crete. Eur J Clin Nutr 2006; 60: 1016–1023
   PubMed Web of Science ®Google Scholar
• Mamalakis G, Kiriakakis M, Tsibinos G, et al. Depression and serum adiponectin and adipose omega-3 and omega-6 fatty acids in adolescents. Pharmacol Biochem Behav 2006; 85: 474–479
   PubMed Web of Science ®Google Scholar
• Hibbeln JR. Fish consumption and major depression. Lancet 1998; 351: 1213
   PubMed Web of Science ®Google Scholar
• Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998; 48: 149–155
   PubMed Web of Science ®Google Scholar
• Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002; 59: 913–919
   PubMed Web of Science ®Google Scholar
• Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003; 13: 267–271
   PubMed Web of Science ®Google Scholar
• Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002; 159: 477–479
   PubMed Web of Science ®Google Scholar
• Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003; 160: 996–998
   PubMed Web of Science ®Google Scholar
• Silvers KM, Woolley CC, Hamilton FC, Watts PM, Watson RA. Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 2005; 72: 211–218
   PubMed Web of Science ®Google Scholar
• Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 2006; 163: 1100–1102
   PubMed Web of Science ®Google Scholar
• Appleton KM, Hayward RC, Gunnell D, et al. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr 2006; 84: 1308–1316
   PubMed Web of Science ®Google Scholar
• Freeman MP, Hibbeln JR, Wisner KL, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006; 67: 1954–1967
   PubMed Web of Science ®Google Scholar
• Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006; 163: 969–978
   PubMed Web of Science ®Google Scholar
• Puri BK, Counsell SJ, Richardson AJ, Horrobin DF. Eicosapentaenoic acid in treatment-resistant depression. Arch Gen Psychiatry 2002; 59: 91–92
   PubMed Web of Science ®Google Scholar
• Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999; 56: 407–412
   PubMed Web of Science ®Google Scholar
• Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 2006; 188: 46–50
   PubMed Web of Science ®Google Scholar
• Keck PE, Jr, Mintz J, McElroy S, et al. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 2006; 60: 1020–1022
   PubMed Web of Science ®Google Scholar
• Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 2006; 163: 1098–1100
   PubMed Web of Science ®Google Scholar
• Freeman MP, Hibbeln JR, Wisner KL, Watchman M, Gelenberg AJ. An open trial of omega-3 fatty acids for depression in pregnancy. Acta Neuropsychiatr 2006; 18: 21–24
   PubMed Web of Science ®Google Scholar
• Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2006; 113: 31–35
   PubMed Web of Science ®Google Scholar
• Osher Y, Bersudsky Y, Belmaker RH. Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. J Clin Psychiatry 2005; 66: 726–729
   PubMed Web of Science ®Google Scholar
• Chiu CC, Huang SY, Shen WW, Su KP. Omega-3 fatty acids for depression in pregnancy. Am J Psychiatry 2003; 160: 385
   PubMed Web of Science ®Google Scholar
• Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L. Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 2005; 35: 691–699
   PubMed Web of Science ®Google Scholar
• Marangell LB, Martinez JM, Zboyan HA, Chong H, Puryear LJ. Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study. Depress Anxiety 2004; 19: 20–23
   PubMed Web of Science ®Google Scholar
• Verlengia R, Gorjao R, Kanunfre CC, et al. Comparative effects of eicosapentaenoic acid and docosahexaenoic acid on proliferation, cytokine production, and pleiotropic gene expression in Jurkat cells. J Nutr Biochem 2004; 15: 657–665
   PubMed Web of Science ®Google Scholar
• Smith, RS. The macrophage theory of depression. Med Hypotheses 1991; 35:298–306, [Erratum: Med Hypotheses 1991; 36:178].
   PubMed Web of Science ®Google Scholar
• Leonard BE. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 767–780
   PubMed Web of Science ®Google Scholar
• Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 201–217
   PubMed Web of Science ®Google Scholar
• Sublette ME, Russ MJ, Smith GS. Evidence for a role of the arachidonic acid cascade in affective disorders: a review. Bipolar Disord 2004; 6: 95–105
   PubMed Web of Science ®Google Scholar
• Obajimi O, Black KD, MacDonald DJ, Boyle RM, Glen I, Ross BM. Differential effects of eicosapentaenoic and docosahexaenoic acids upon oxidant-stimulated release and uptake of arachidonic acid in human lymphoma U937 cells. Pharmacol Res 2005; 52: 183–191
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Begg D, Mathai M, Weisinger RS. Omega 3 fatty acids and the brain: review of studies in depression. Asia Pac J Clin Nutr 2007; 16(Suppl 1)391–397
   PubMed Web of Science ®Google Scholar
• Massart N, Triffaux JM. Depression and coronary artery disease]. Rev Med Liege 2005; 60: 931–938
   PubMedGoogle Scholar
• Aukrust P, Yndestad A, Smith C, Ueland T, Gullestad L, Damas JK. Chemokines in cardiovascular risk prediction. Thromb Haemost 2007; 97: 748–754
   PubMed Web of Science ®Google Scholar
• Pavon L, Sandoval-Lopez G, Eugenia Hernandez M, et al. Th2 cytokine response in major depressive disorder patients before treatment. J Neuroimmunol 2006; 172: 156–165
   PubMed Web of Science ®Google Scholar
• Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83: 1505S–1519S
   PubMed Web of Science ®Google Scholar